BNP Paribas Financial Markets
PNT

BNP Paribas Financial Markets’s POINT Biopharma Global Inc. Common Stock PNT Stock Holding History

BNP Paribas Financial Markets’s Portfolio PNT Stock Details PNT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-69,078
Closed -$534K – 4803
2022
Q3 		$534K Buy
+69,078
New +$586K ﹤0.01% 2934

Other funds holding PNT

BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return

BNP Paribas Financial Markets's PNT Position: Q4 2022 in Review

BNP Paribas Financial Markets sold out of POINT Biopharma Global Inc. Common Stock (PNT) in Q4 2022, closing a stake of 69,078 shares — an estimated $534K sold.

BNP Paribas Financial Markets first reported a position in PNT in Q3 2022 and held it in 1 quarter. The position peaked at $534K in Q3 2022. 109 funds tracked by Wall St. Rank hold PNT as of Q4 2022.

  • BNP Paribas Financial Markets reported no remaining POINT Biopharma Global Inc. Common Stock position as of Q4 2022 after selling out during the quarter.
  • BNP Paribas Financial Markets sold 69,078 POINT Biopharma Global Inc. Common Stock shares in Q4 2022, an estimated $534K.
  • BNP Paribas Financial Markets first reported a position in POINT Biopharma Global Inc. Common Stock in Q3 2022 and held it in 1 quarter.
  • BNP Paribas Financial Markets's POINT Biopharma Global Inc. Common Stock position peaked at $534K in Q3 2022.
  • 109 funds tracked by Wall St. Rank held POINT Biopharma Global Inc. Common Stock as of Q4 2022.

Based on BNP Paribas Financial Markets's 13F filing for Q4 2022, filed 14 Feb 2023.